TY - JOUR
T1 - Gender inequity
T2 - Enough talk, time for action
AU - Barner, Jamie C.
AU - Quiñones-Boex, Ana C.
AU - Warholak, Terri
N1 - Publisher Copyright:
© 2022 American Pharmacists Association®
PY - 2023/1/1
Y1 - 2023/1/1
N2 - While gender inequity has been shown to be an ongoing issue in the pharmacy profession, it has moved to the forefront due to increasing numbers of women in pharmacy. Two national organizations, American Pharmacists Association (APhA) and American Association of Colleges of Pharmacy (AACP) convened a joint Gender Equity Task Force to examine this matter among social and administrative sciences pharmacy faculty. The Task Force launched a survey and conducted interviews, as well as held several forums to solicit recommendations. This commentary provides recommendations for pharmacy constituents and stakeholders regarding: training and programming, leadership and mentoring, policy, and expansion. The goal is for organizations and leadership to incorporate recommendations with the goal of closing the gap in gender inequity.
AB - While gender inequity has been shown to be an ongoing issue in the pharmacy profession, it has moved to the forefront due to increasing numbers of women in pharmacy. Two national organizations, American Pharmacists Association (APhA) and American Association of Colleges of Pharmacy (AACP) convened a joint Gender Equity Task Force to examine this matter among social and administrative sciences pharmacy faculty. The Task Force launched a survey and conducted interviews, as well as held several forums to solicit recommendations. This commentary provides recommendations for pharmacy constituents and stakeholders regarding: training and programming, leadership and mentoring, policy, and expansion. The goal is for organizations and leadership to incorporate recommendations with the goal of closing the gap in gender inequity.
UR - https://www.scopus.com/pages/publications/85138510382
UR - https://www.scopus.com/inward/citedby.url?scp=85138510382&partnerID=8YFLogxK
U2 - 10.1016/j.japh.2022.08.016
DO - 10.1016/j.japh.2022.08.016
M3 - Comment/debate
C2 - 36137927
AN - SCOPUS:85138510382
SN - 1544-3191
VL - 63
SP - 39
EP - 42
JO - Journal of the American Pharmacists Association
JF - Journal of the American Pharmacists Association
IS - 1
ER -